Legal Representation
Attorney
Richard T. Matthews
USPTO Deadlines
Application History
40 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 9, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 22, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 22, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Aug 22, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 24, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 23, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 23, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 23, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 23, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 21, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 21, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 21, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 16, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 25, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 23, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 23, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 23, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 23, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 28, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 28, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 8, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 20, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 19, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 19, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 19, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 19, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 11, 2022 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Apr 12, 2022 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Mar 31, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 31, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 30, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 30, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 17, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 17, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 17, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 11, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 7, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 25, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 040
Processing of medicinal plants, namely, extraction and processing of hemp for the production of hemp-based health and science products; all of the foregoing services featuring ingredients derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Class 042
Pharmaceutical product evaluation and development; pharmaceutical research services; product research and development in the field of hemp-based health and science products; all of the foregoing services featuring ingredients derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Additional Information
Pseudo Mark
AVERIX BIOSCIENCES
Classification
International Classes
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIO"